MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$1,164,315
Net Income
-$2,570,709
Net Profit Margin
-220.79%
EPS
-$0.2
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Federal grants
1,164,315
960,999
1,882,336
493,104
Research and development
2,471,752
3,346,881
3,613,028
2,954,909
General and administrative
1,268,952
1,176,348
1,051,132
1,279,290
Total operating expenses
3,740,704
4,523,229
4,664,160
4,234,199
Loss from operations
-2,576,389
-3,562,230
-2,781,824
-3,741,095
Change in fair value of liability classified warrants
-
-
35
998
Interest expense, net
320
3,923
5,382
6,369
Other income and expense, net
5,834
9,738
19,202
17,338
Total other income (expense), net
5,514
5,815
13,855
11,967
Net loss
-2,570,875
-3,556,415
-2,767,969
-3,729,128
Net gain attributable to noncontrolling interests
-166
-
-321
-
Net loss attributable to common stockholders
-2,570,709
-3,556,415
-2,767,648
-3,729,128
Basic EPS
-0.2
-0.52
-1.082
-1.29
Diluted EPS
-0.2
-0.52
-1.082
-1.29
Basic Average Shares
13,035,632
6,839,385
2,557,377*
2,886,059
Diluted Average Shares
13,035,632
6,839,385
2,557,377*
2,886,059
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$2,570,709 (-48.31%↓ Y/Y)Net gainattributable to...-$166 (0.00%↑ Y/Y)Other income andexpense, net$5,834 (-72.23%↓ Y/Y)Net loss-$2,570,875 (-48.30%↓ Y/Y)Total other income(expense), net$5,514 (-67.56%↓ Y/Y)Interest expense, net$320 (-89.87%↓ Y/Y)Loss from operations-$2,576,389 (-47.18%↓ Y/Y)Federal grants$1,164,315 (-15.10%↓ Y/Y)Total operatingexpenses$3,740,704 (19.82%↑ Y/Y)Research and development$2,471,752 (28.51%↑ Y/Y)General andadministrative$1,268,952 (5.88%↑ Y/Y)

Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences, Inc. (ENSC)